Trial intelligence / Profile preview

N-acetylcysteine in men with terato-asthenozoospermia

IRCT20170830035998N4Phase 2Completed

Sponsor
Qom Infertility Center
Start
Feb 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, open-label trial of acetylcysteine in Teratoasthenozoospermia and male infertility (2 arms), sponsored by Qom Infertility Center. Primary endpoints: Sperm morphology, Sperm motility and 6 more. Started Feb 2018; status: completed.

02

Drugs

acetylcysteine
03

Conditions

Teratoasthenozoospermiamale infertility

Beyond the preview

Go deeper on IRCT20170830035998N4.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20170830035998N4.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call